Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 2 |
Pissara et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 4 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 4 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Related structures:
AlphaFold database: A4HEB3
Term | Name | Level | Count |
---|---|---|---|
GO:0006457 | protein folding | 2 | 15 |
GO:0009987 | cellular process | 1 | 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 17 |
GO:0005515 | protein binding | 2 | 15 |
GO:0030544 | Hsp70 protein binding | 4 | 15 |
GO:0031072 | heat shock protein binding | 3 | 15 |
GO:0051879 | Hsp90 protein binding | 4 | 15 |
GO:0003676 | nucleic acid binding | 3 | 8 |
GO:0008270 | zinc ion binding | 6 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
GO:0046914 | transition metal ion binding | 5 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 158 | 162 | PF00656 | 0.425 |
CLV_NRD_NRD_1 | 289 | 291 | PF00675 | 0.519 |
CLV_NRD_NRD_1 | 353 | 355 | PF00675 | 0.524 |
CLV_PCSK_FUR_1 | 353 | 357 | PF00082 | 0.551 |
CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.544 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.465 |
CLV_PCSK_KEX2_1 | 353 | 355 | PF00082 | 0.539 |
CLV_PCSK_PC1ET2_1 | 115 | 117 | PF00082 | 0.502 |
CLV_PCSK_PC1ET2_1 | 34 | 36 | PF00082 | 0.465 |
CLV_PCSK_PC1ET2_1 | 355 | 357 | PF00082 | 0.540 |
CLV_PCSK_SKI1_1 | 16 | 20 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 171 | 175 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 204 | 208 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 302 | 306 | PF00082 | 0.570 |
DEG_APCC_DBOX_1 | 15 | 23 | PF00400 | 0.354 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.469 |
DOC_CYCLIN_RxL_1 | 186 | 198 | PF00134 | 0.516 |
DOC_MAPK_gen_1 | 34 | 41 | PF00069 | 0.263 |
DOC_MAPK_gen_1 | 88 | 96 | PF00069 | 0.325 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.506 |
DOC_USP7_MATH_1 | 286 | 290 | PF00917 | 0.589 |
DOC_USP7_MATH_1 | 316 | 320 | PF00917 | 0.593 |
DOC_USP7_MATH_1 | 328 | 332 | PF00917 | 0.568 |
DOC_USP7_UBL2_3 | 233 | 237 | PF12436 | 0.559 |
DOC_USP7_UBL2_3 | 249 | 253 | PF12436 | 0.499 |
LIG_14-3-3_CanoR_1 | 302 | 311 | PF00244 | 0.582 |
LIG_Actin_WH2_2 | 238 | 255 | PF00022 | 0.463 |
LIG_FHA_1 | 261 | 267 | PF00498 | 0.456 |
LIG_FHA_1 | 299 | 305 | PF00498 | 0.571 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.547 |
LIG_FHA_2 | 198 | 204 | PF00498 | 0.544 |
LIG_FHA_2 | 290 | 296 | PF00498 | 0.514 |
LIG_FHA_2 | 51 | 57 | PF00498 | 0.437 |
LIG_LIR_Gen_1 | 257 | 266 | PF02991 | 0.418 |
LIG_LIR_Gen_1 | 334 | 341 | PF02991 | 0.569 |
LIG_LIR_Gen_1 | 50 | 58 | PF02991 | 0.504 |
LIG_LIR_Gen_1 | 74 | 85 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 257 | 262 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 334 | 338 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.491 |
LIG_LIR_Nem_3 | 74 | 80 | PF02991 | 0.432 |
LIG_PTB_Apo_2 | 131 | 138 | PF02174 | 0.338 |
LIG_PTB_Phospho_1 | 131 | 137 | PF10480 | 0.340 |
LIG_RPA_C_Fungi | 206 | 218 | PF08784 | 0.342 |
LIG_RPA_C_Fungi | 285 | 297 | PF08784 | 0.596 |
LIG_SH2_CRK | 259 | 263 | PF00017 | 0.416 |
LIG_SH2_CRK | 77 | 81 | PF00017 | 0.325 |
LIG_SH2_NCK_1 | 117 | 121 | PF00017 | 0.402 |
LIG_SH2_NCK_1 | 124 | 128 | PF00017 | 0.386 |
LIG_SH2_NCK_1 | 52 | 56 | PF00017 | 0.413 |
LIG_SH2_SRC | 117 | 120 | PF00017 | 0.348 |
LIG_SH2_SRC | 181 | 184 | PF00017 | 0.506 |
LIG_SH2_STAP1 | 117 | 121 | PF00017 | 0.264 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.414 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.536 |
LIG_SH2_STAT5 | 335 | 338 | PF00017 | 0.429 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.422 |
LIG_SH3_3 | 92 | 98 | PF00018 | 0.196 |
LIG_SUMO_SIM_anti_2 | 92 | 97 | PF11976 | 0.196 |
LIG_TRAF2_1 | 109 | 112 | PF00917 | 0.481 |
LIG_TRAF2_1 | 175 | 178 | PF00917 | 0.529 |
LIG_TRAF2_1 | 292 | 295 | PF00917 | 0.519 |
LIG_UBA3_1 | 19 | 23 | PF00899 | 0.344 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.349 |
MOD_CK1_1 | 289 | 295 | PF00069 | 0.589 |
MOD_CK1_1 | 319 | 325 | PF00069 | 0.616 |
MOD_CK1_1 | 331 | 337 | PF00069 | 0.642 |
MOD_CK1_1 | 347 | 353 | PF00069 | 0.369 |
MOD_CK1_1 | 50 | 56 | PF00069 | 0.478 |
MOD_CK2_1 | 125 | 131 | PF00069 | 0.453 |
MOD_CK2_1 | 197 | 203 | PF00069 | 0.442 |
MOD_CK2_1 | 289 | 295 | PF00069 | 0.509 |
MOD_CK2_1 | 342 | 348 | PF00069 | 0.446 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.435 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.422 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.552 |
MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.343 |
MOD_GlcNHglycan | 222 | 226 | PF01048 | 0.386 |
MOD_GlcNHglycan | 318 | 321 | PF01048 | 0.508 |
MOD_GlcNHglycan | 330 | 333 | PF01048 | 0.638 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.463 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.314 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.523 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.636 |
MOD_GSK3_1 | 324 | 331 | PF00069 | 0.732 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.350 |
MOD_LATS_1 | 300 | 306 | PF00433 | 0.430 |
MOD_N-GLC_1 | 209 | 214 | PF02516 | 0.338 |
MOD_N-GLC_1 | 339 | 344 | PF02516 | 0.557 |
MOD_N-GLC_1 | 71 | 76 | PF02516 | 0.280 |
MOD_N-GLC_2 | 337 | 339 | PF02516 | 0.560 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.479 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.452 |
MOD_PKA_1 | 354 | 360 | PF00069 | 0.575 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.386 |
MOD_PKA_2 | 289 | 295 | PF00069 | 0.563 |
MOD_PKB_1 | 296 | 304 | PF00069 | 0.499 |
MOD_Plk_1 | 347 | 353 | PF00069 | 0.425 |
MOD_Plk_1 | 59 | 65 | PF00069 | 0.314 |
MOD_Plk_4 | 347 | 353 | PF00069 | 0.628 |
MOD_SUMO_rev_2 | 156 | 162 | PF00179 | 0.531 |
MOD_SUMO_rev_2 | 230 | 239 | PF00179 | 0.273 |
TRG_DiLeu_BaEn_1 | 203 | 208 | PF01217 | 0.500 |
TRG_ENDOCYTIC_2 | 24 | 27 | PF00928 | 0.330 |
TRG_ENDOCYTIC_2 | 259 | 262 | PF00928 | 0.415 |
TRG_ENDOCYTIC_2 | 335 | 338 | PF00928 | 0.561 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.364 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.376 |
TRG_ER_diArg_1 | 1 | 4 | PF00400 | 0.469 |
TRG_ER_diArg_1 | 352 | 354 | PF00400 | 0.530 |
TRG_ER_diArg_1 | 356 | 359 | PF00400 | 0.550 |
TRG_ER_diArg_1 | 65 | 68 | PF00400 | 0.392 |
TRG_NES_CRM1_1 | 84 | 97 | PF08389 | 0.196 |
TRG_NLS_MonoExtC_3 | 353 | 358 | PF00514 | 0.524 |
TRG_NLS_MonoExtN_4 | 353 | 359 | PF00514 | 0.535 |
TRG_Pf-PMV_PEXEL_1 | 277 | 281 | PF00026 | 0.477 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTR8 | Leptomonas seymouri | 25% | 100% |
A0A0N1IBD2 | Leptomonas seymouri | 63% | 100% |
A0A0S4JRK3 | Bodo saltans | 34% | 100% |
A0A1X0NZH9 | Trypanosomatidae | 39% | 98% |
A0A3Q8IJP8 | Leishmania donovani | 24% | 100% |
A0A3R7LE97 | Trypanosoma rangeli | 40% | 100% |
A0A3S7WZC1 | Leishmania donovani | 84% | 100% |
A4I1Q9 | Leishmania infantum | 84% | 100% |
A4ICY0 | Leishmania infantum | 24% | 100% |
C9ZKB4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9ASC5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9AXU3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4Q271 | Leishmania major | 25% | 100% |
Q4Q9M8 | Leishmania major | 82% | 100% |
V5BCJ3 | Trypanosoma cruzi | 40% | 100% |